AKL Research and Development
AKL Research & Development Ltd.'s focus is in inflammatory diseases, particularly those related to dysregulation of the innate immune system.
AKLRD identifies secondary metabolites of plant origin with proven efficacy & safety, and which are capable of being synthesized. These synthetic metabolites then undergo standard pharmaceutical clinical development. This innovative approach greatly increases the chances of success, while reducing the probability of unexpected side effects.
See other Therapeutics organisations
-
Antabio is a private biopharmaceutical company developing a broad pipeline of novel antibacterial treatments focused on drug-resistant life threatening infections. ... -
To 2014 - Antikor Biopharma Limited was established in mid-2014 following the restructuring of PhotoBiotics Limited. The new Company retains ... -
Autifony Therapeutics aims to develop new drugs to treat serious disorders of the central nervous system using pioneering science -
Collaborative Community Against Coronavirus (3C) CIC was formed in March 2020. Frustrated at the inability of the available treatments to ...
Stevenage Bioscience Catalyst is the UK's leading open innovation campus with a focus on therapeutics.
Learn moreCopyright © 2023 Stevenage Bioscience Catalyst
We use cookies to improve our site experience. Press accept to agree to our Cookie Policy. If you decline, your information won’t be tracked when you visit this website. A single cookie will be used in your browser to remember your preference not to be tracked.